CTI BIOPHARMA CORP (CTIC)

US12648L6011 - Common Stock

9.09  0 (0%)

After market: 9.09 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
75.77M53.95M0.000.003.35M
Minority Interest Expense
N/AN/AN/A0.000.00
Cost Of Goods
4.46M3.51MN/AN/AN/A
Gross Profit
71.31M50.43MN/AN/AN/A
Operating Expenses
125.24M130.23M95.33M43.57M43.27M
Research and Development
39.06M36.90M39.14M25.94M24.11M
Selling, General, and Administrative Expenses
88.69M84.83M56.20M17.63M19.16M
Operating Income
-53.93M-79.80M-95.33M-43.57M-39.92M
Interest Income/Expense
-15.28M-13.14M-2.44M-910.00K-630.00K
Other Income/Expense
N/A-56.00KN/A-3.77M1.32M
Non Recurring Items
N/AN/A-138.00K-4.20M-790.00K
Income Before Taxes
-69.24M-92.99M-97.91M-52.45M-40.02M
Net Income
-69.24M-92.99M-97.91M-52.45M-40.02M
EBITDA
-51.77M-77.85M-94.81M-43.04M-39.37M
 
Per Share Data
EPS Diluted Total Ops
-0.58-0.81-1.09-0.74-0.69
Non GAAP EPS
-0.58-0.85-1.08-0.69-0.69
 
Statistics
Gross Profit Margin
94.11%93.49%N/AN/AN/A
Profit Margin
-91.38%-172.37%N/AN/A-1194.63%
Operating Profit Margin
-71.18%-147.91%N/AN/A-1191.64%

All data in USD

Charts